Evidence map›Paper›PMID 10887488›Full record

ReviewJournal of mammary gland biology and neoplasia1996

Genetic analysis of breast cancer progression.

S H Dairkee, H S Smith

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S H DairkeeGeraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco 94115, USA.
H S Smith
California Pacific Medical Center · US

Funding

Tissue and Outcomes CoreP50CA058207 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRAY, JOE W. · 1992 to 2012
$32.7M
TRANSFORMING GENES EXPRESSION IN BREAST CANCERP01CA044768 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BENZ, CHRISTOPHER · 1987 to 2000
$890k
SELECTIVE ISOLATION OF TRANSFORMED BREAST EPITHELIUMR01CA066998 · NCI · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI DAIRKEE, SHANAZ H · 1994 to 1996
–
NCI NIH HHS 1P59-CA58207NCI NIH HHS P01-CA44768NCI NIH HHS R01-CA66998
6 · The paper itself

Abstract

At the histological level, breast tumors display a variety of morphologic lesions which suggest the existence of an increasingly aberrant pathway of intermediate steps leading to the invasive primary tumor and its metastatic dissemination. In order to obtain direct evidence for this presumed progression, underlying genetic changes must be identified. Analyses of primary breast tumors have revealed a large number of dominant and recessive gene alterations encompassing several cellular attributes and activities. It is quite likely that some of these alterations are of a causal nature and thus enable the tumor to attain distinctive malignant phenotypes, such as, dysregulated proliferation, invasion, angiogenesis, and ability to metastasize. Considerable heterogeneity has been observed in the sequence of acquisition of these genetic changes, which is substantiated by recent comparative analyses between carefully microdissected preinvasive and invasive tumor. The data are evaluated here in the context of existing models of breast cancer progression. Implication and prospects for translational application to the clinic are also discussed.

Indexed as

Gene Expression Regulation, NeoplasticBreast NeoplasmsFemaleHumansNeoplasm Metastasis

Identifiers

PMID10887488
OpenAlexW2019796952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.